¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"prostatic specific antigen"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
granulocyte-specific antigen
°ú¸³±¸Æ¯ÀÌÇ׿ø
group-specific antigen
¹«¸®Æ¯ÀÌÇ׿ø, ±ºÆ¯ÀÌÇ׿ø
organ specific antigen
Àå±âƯÀÌÇ׿ø
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
prostate specific antigen
Àü¸³»ùƯÀÌÇ׿ø
species-specific antigen
Á¾Æ¯ÀÌÇ׿ø
specific antigen
ƯÀÌÇ׿ø
benign prostatic hypertrophy
¾ç¼ºÀü¸³»ùºñ´ë, ¾ç¼ºÀü¸³¼±ºñ´ë
prostatic
Àü¸³»ù-, Àü¸³¼±-
prostatic adenoma
Àü¸³»ùÁ¾
prostatic artery
Àü¸³»ùµ¿¸Æ, Àü¸³¼±µ¿¸Æ
prostatic cancer
Àü¸³»ù¾Ï, Àü¸³¼±¾Ï
prostatic concretion
Àü¸³»ùµ¹, Àü¸³¼±°á¼®
prostatic ductule
Àü¸³»ù¼¼°ü
prostatic fluid
Àü¸³»ù¾×, Àü¸³¼±¾×
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
prostatic cancer
Àü¸³»ù¾Ï
specific activity
ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
specific gravity
ºñÁß
specific phobia
ƯÁ¤°øÆ÷(Áõ)
specific
ƯÀÌ-, ƯÁ¤-
antigen
Ç׿ø
antigen analysis
Ç׿øºÐ¼®
carcinoembryonic antigen
¾ÏÁ¾¹è¾ÆÇ׿ø
recombinant antigen
ÀçÁ¶ÇÕÇ׿ø
sequestered antigen
°Ý¸®Ç׿ø
somatic antigen
ü¼¼Æ÷Ç׿ø, ±ÕüÇ׿ø
surface antigen
Ç¥¸éÇ׿ø
tumor antigen
Á¾¾çÇ׿ø
antigen excess
Ç׿ø°úÀ×
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
granulocyte-specific antigen
°ú¸³±¸Æ¯ÀÌÇ׿ø
group-specific antigen
±ºÆ¯ÀÌÇ׿ø
organ specific antigen
Àå±âƯÀÌÇ׿ø
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
specific antigen
ƯÀÌÇ׿ø
type specific antigen
ÇüƯÀÌÇ׿ø
prostatic adenoma
Àü¸³»ùÁ¾
prostatic artery
Àü¸³»ùµ¿¸Æ
benign prostatic hypertrophy
¾ç¼ºÀü¸³»ùºñ´ë
prostatic concretion
Àü¸³»ùµ¹
prostatic
Àü¸³»ù-
prostatic sinus
Àü¸³»ù±¼
prostatic utricle
Àü¸³»ù¼Ò½Ç
prostatic urinary sphincter
Àü¸³»ù¿äµµÁ¶ÀÓ±Ù
age-specific rate
¿¬·Éº°Æ¯¼öÀ²
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
prostatic specific antigen
Àü¸³¼± ƯÀÌÇ׿ø
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigen, species-specific
Á¾Æ¯ÀÌÇ׿ø
antigen, tumor-specific
Á¾¾çƯÀÌÇ׿ø
antigen, tumor-specific transplantation
Á¾¾çƯÀÌ À̽ÄÇ׿ø
antigen,tumor-specific transplantation
Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
group-specific antigen
±ºÆ¯ÀÌÇ׿ø
group-specific antigen
±º-ƯÀÌÇ׿ø
prostate specific antigen
Àü¸³¼±Æ¯ÀÌÇ׿ø
prostate-specific antigen
Àü¸³¼±Æ¯ÀÌÇ׿ø(îñí¡àÍ÷åì¶ù÷ê«)
SDA= specific dynamic action
ƯÀ̵¿Àû ÀÛ¿ë.
age specific death rate
¿¬·Éº° »ç¸Á·ü
granulocyte-specific antigens
°ú¸³±¸Æ¯ÀÌÇ׿ø
group specific C carbohydrate
±ºÆ¯ÀÌ C´Ù´çü.
group-specific
±ºÆ¯ÀÌÀÇ
group-specific C carbohydrate
±ºÆ¯ÀÌ C ź¼öȹ°
idiotype specific regulatory cell
°³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
prostatic specific antigen
Àü¸³¼± ƯÀÌÇ׿ø
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigen, species-specific
Á¾Æ¯ÀÌÇ׿ø
antigen, tumor-specific
Á¾¾çƯÀÌÇ׿ø
antigen, tumor-specific transplantation
Á¾¾çƯÀÌ À̽ÄÇ׿ø
antigen,tumor-specific transplantation
Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
group-specific antigen
±º-ƯÀÌÇ׿ø
group-specific antigen
±ºÆ¯ÀÌÇ׿ø
male-specific antigen
¿õ¼º¼¼Æ÷ƯÀÌÇ׿ø
neutrophil specific antigen
È£Áß±¸Æ¯ÀÌÇ׿ø.
organ specific antigen
±â°ü<Àå±â>ƯÀÌÇ׿ø(¡÷åì¶ù÷ê«).
prostate specific antigen
Àü¸³¼±Æ¯ÀÌÇ׿ø
prostate-specific antigen
Àü¸³¼±Æ¯ÀÌÇ׿ø(îñí¡àÍ÷åì¶ù÷ê«)
species specific antigen
Á¾Æ¯ÀÌÇ׿ø(ðú÷åì¶ù÷ê«).
specific antigen, organ
Àå±âƯÀÌÇ׿ø
tissue specific antigen
Á¶Á÷ƯÀÌÇ׿ø(¡÷åì¶ù÷ê«).
tumor specific antigen
Á¾¾çƯÀÌ(¼º)Ç׿ø(ðþåË÷åì¶àõù÷ê«).
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½